MiNK Therapeutics, Inc. (INKT)
- Previous Close
0.8717 - Open
0.8705 - Bid 0.8452 x 100
- Ask 0.9348 x 100
- Day's Range
0.8705 - 0.9000 - 52 Week Range
0.7500 - 3.3400 - Volume
16,909 - Avg. Volume
99,420 - Market Cap (intraday)
30.535M - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6500 - Earnings Date May 11, 2024 - May 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.00
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
minktherapeutics.comRecent News: INKT
Performance Overview: INKT
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INKT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INKT
Valuation Measures
Market Cap
30.25M
Enterprise Value
26.88M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-1.18
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-110.10%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-22.46M
Diluted EPS (ttm)
-0.6500
Balance Sheet and Cash Flow
Total Cash (mrq)
3.37M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-11.08M
Research Analysis: INKT
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell